BioAtla Corp (BCAB)
NGM · Common · CUSIP 09077B104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BCAB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09077B104
Market Cap
Large Cap
IPO
12/16/2020 · $18.00/share
Business: BioAtla Corp is a clinical-stage biopharmaceutical company developing a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancers.

Company Contact

CEO
Jay M. Short
CFO
Richard A. Waldron
Headquarters
11085 Torreyana Road, San Diego, CA 92121
Phone
858-558-0708
Investor Relations
Richard A. Waldron · 858-558-0708 · rwaldron@bioatla.com
SEC EDGAR Filings
View filings »